From Enhertu Pipeline to Global Impact: A Story of Advancement in Cancer Care
Cancer has long been a formidable adversary in the field of medicine, affecting millions of lives worldwide. However, in recent years, revolutionary advancements in cancer treatment have brought hope to patients and healthcare professionals alike. One such breakthrough is the emergence of ENHERTU , a cutting-edge therapy with the potential to transform cancer management. In this blog, we will explore ENHERTU's journey in cancer treatment and its impact on various types of cancers. How is it different from other chemotherapy drugs? ENHERTU , developed by Daiichi Sankyo and AstraZeneca, belongs to a novel class of drugs known as antibody-drug conjugates (ADCs). Unlike traditional chemotherapy, which indiscriminately attacks both cancerous and healthy cells, ENHERTU is designed to deliver its payload selectively to cancer cells, minimizing damage to surrounding tissues. This targeted approach reduces the severity of side effects, enhancing the overall quality of life for patients duri...